These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23141173)

  • 21. Does Chemotherapy for Gynecological Malignancies during Pregnancy Cause Fetal Growth Restriction?
    Abdalla N; Bizoń M; Piórkowski R; Stanirowski P; Cendrowski K; Sawicki W
    Biomed Res Int; 2017; 2017():7543421. PubMed ID: 28626764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of chemosensitivity of gynecological cancer cell lines by the subrenal capsule assay].
    Kubo H; Ueda M; Maeda T; Yamada T; Yanagawa Y; Miyawaki Y; Misaki O; Ueki M; Sugimoto O
    Nihon Gan Chiryo Gakkai Shi; 1988 Apr; 23(4):837-43. PubMed ID: 3204308
    [No Abstract]   [Full Text] [Related]  

  • 23. [Bacterial vaginosis during chemotherapy for gynecological neoplasms. A therapeutic proposal].
    Carta G; Di Stefano L; Porzio G; Caserta D; Mascaretti G
    Minerva Ginecol; 1995; 47(1-2):5-8. PubMed ID: 7770150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chemotherapy of malignant gynecological tumor--arterial infusion and biological response modifiers(BRM)].
    Fujiwara S; Akiya K
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Nov; 35(11):2025-30. PubMed ID: 6663134
    [No Abstract]   [Full Text] [Related]  

  • 25. Optimal therapy for relapsed carcinoma of the cervix after primary chemoradiation.
    Mano M; Kerr J
    J Clin Oncol; 2004 Dec; 22(24):5021-2; author reply 5022. PubMed ID: 15611523
    [No Abstract]   [Full Text] [Related]  

  • 26. Gynecological cancers.
    Boente MP; Schilder R; Ozols RF
    Cancer Chemother Biol Response Modif; 1999; 18():418-34. PubMed ID: 10800496
    [No Abstract]   [Full Text] [Related]  

  • 27. Chemotherapy for gynecologic malignancies at Siriraj Hospital, Bangkok.
    Senapad S
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):656-9. PubMed ID: 3939044
    [No Abstract]   [Full Text] [Related]  

  • 28. [Emphasis in the prevention and management of chemotherapy-reduced toxicity in gynecological malignancies].
    Shen K
    Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):881-3. PubMed ID: 22333274
    [No Abstract]   [Full Text] [Related]  

  • 29. [Neoadjuvant chemotherapy in advanced gynecologic cancer].
    Hirabayashi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Aug; 47(8):797-802. PubMed ID: 7594888
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of remission induction chemotherapy on blood coagulability in patients with gynecological malignancies].
    Sawaguchi K; Yabushita H; Higuchi K; Noguchi M; Ishihara M; Aoyama T; Menjoh H; Oguri T
    Nihon Gan Chiryo Gakkai Shi; 1989 Apr; 24(4):798-808. PubMed ID: 2778374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chemotherapy for gynecologic tumors].
    Machover D
    Contracept Fertil Sex; 1996 Apr; 24(4):264-7. PubMed ID: 8704799
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical significance of cell-free and concentrated ascites re-infusion therapy for advanced and recurrent gynecological cancer.
    Ueda T; Maehara M; Takahashi Y; Nakayama N; Kondo H; Shirota K; Yoshizato T; Miyamoto S
    Anticancer Res; 2012 Jun; 32(6):2353-7. PubMed ID: 22641674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Individualized systemic gynecologic tumor therapy in gynecology].
    Schmidt-Matthiesen H; Schnürch HG
    Gynakologe; 1988 Dec; 21(4):319-22. PubMed ID: 3061893
    [No Abstract]   [Full Text] [Related]  

  • 34. [Chemotherapy of a second instance of carcinoma of the ovary].
    Giaccone G; Clerico M; Donadio M; Calciati A
    Minerva Ginecol; 1984 Apr; 36(4):209-12. PubMed ID: 6462524
    [No Abstract]   [Full Text] [Related]  

  • 35. [Granisetron, a new and potent antiemetic for treatment of cytostatic drug-induced vomiting in gynecological malignancies].
    Regidor PA; Schindler AE
    Geburtshilfe Frauenheilkd; 1994 Jan; 54(1):51-4. PubMed ID: 8150251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy for ovarian cancer: an evidence-based approach.
    Geisler JP; Manahan KJ; Wiemann MC
    Minerva Ginecol; 2004 Dec; 56(6):539-45. PubMed ID: 15729206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The rule and strategy of chemotherapy in gynecologic malignancy].
    Shen K
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2089-90. PubMed ID: 16313812
    [No Abstract]   [Full Text] [Related]  

  • 38. Cisplatin, adriamycin and ifosfamide-based combination chemotherapy for gynecological cancers derived from the extended müllerian system.
    Nishida T; Nagasue N; Izumi S; Sakihama H; Yakushiji M
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):193-8. PubMed ID: 1690254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current trends in obstetrical-gynecological antiblastic chemotherapy].
    Variati G
    Ann Ostet Ginecol Med Perinat; 1966 Oct; 88(10):797-806. PubMed ID: 6011759
    [No Abstract]   [Full Text] [Related]  

  • 40. [Nursing of gynecological patients treated by chemotherapy].
    Xian M
    Zhonghua Hu Li Za Zhi; 1985 Jun; 20(3):156-8. PubMed ID: 3849358
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.